Last reviewed · How we verify
NCT04467554: T-Chair
Providing Sitting Balance Training With a Newly Developed Rehabilitation Device
NA trial testing T-chair in Stroke in 30 participants. Completed in 13 July 2021.
18 December 2020
Quick facts
| Lead sponsor | KU Leuven |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 30 |
| Start date | 17 July 2020 |
| Primary completion | 18 December 2020 |
| Estimated completion | 13 July 2021 |
| Sites | 1 location across Belgium |
Drugs / interventions tested
- T-chair
Conditions studied
- Stroke — all drugs for Stroke →
Sponsor
KU Leuven — full company profile →
Who can join
Adults 18 to 110, any sex, with Stroke. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This clinical study is being conducted to evaluate a new training device, the T-CHAIR, for trunk rehabilitation and post-stroke balance. The investigators would like to study three objectives. First, the investigators want to examine whether training with a new training device is feasible and safe during rehabilitation in the later phase, more than six months after a stroke. The investigators also evaluate whether training with a new training device has an effect on the sitting balance and the function and strength of the trunk. Finally, the investigators examine whether training with a new training device has an effect on walking, standing and activities of daily life and self-care.
Publications & conference data
3 peer-reviewed publications reference this trial (live from Europe PMC):
-
Technology-supported sitting balance therapy versus usual care in the chronic stage after stroke: a pilot randomized controlled trial.
Thijs L, Voets E, Wiskerke E, Nauwelaerts T, et al · · 2021 · cited 7× · PMID 34321042 · DOI 10.1186/s12984-021-00910-7 -
Main Abstracts.
· 2021 · cited 1× · PMID 35252582 · DOI 10.1177/23969873211034932 -
Technology-supported sitting balance therapy versus usual care in the chronic stage after stroke: A pilot randomized controlled trial
Thijs L, Voets E, Wiskerke E, Nauwelaerts T, et al · · 2021 · DOI 10.21203/rs.3.rs-326548/v1
Verify or expand the search:
- PubMed search for NCT04467554
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Stroke
Currently open trials in the same condition.
- NCT06615973 — Screening for Social Determinants of Health (SDOH) and Cognitive Function in Individuals With History of Stroke · recruiting
- NCT07494890 — Measurement Properties of Mechanical Cost of Walking for Individuals With Walking Impairment · NA · recruiting
- NCT07356011 — Exoskeleton for Balance · NA · recruiting
- NCT07523503 — Unilateral Versus Bilateral Task-specific Training on Motor Impairment, Upper Extremity Function, and Hand Dexterity in · NA · recruiting
- NCT06704074 — Virtual Reality Task Oriented Training on Upper Limb Function in Stroke Patients · NA · recruiting
Other KU Leuven trials
Trials by the same sponsor.
- NCT07508696 — Cerebellar Research in Ultrasound Stimulation · NA · not yet recruiting
- NCT07476716 — Peer-modeled Intervention · NA · not yet recruiting
- NCT07534384 — Automated CPET Interpretation: International Validation Study · not yet recruiting
- NCT07419555 — Belgian Lung Function Study · recruiting
- NCT07295600 — Postprandial Effect of Isocaloric Challenge Meals Enriched With Indigenous Fruits and Vegetables on Glucose Metabolism i · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04467554 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 9 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by KU Leuven
- Last refreshed: 28 January 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04467554.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing